Blake, Cassels & Graydon LLP

IAM Research

The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

Highly-recommended - Firms: transactions

Silver - Firms: litigation

Bronze - Firms: prosecution

Despite a number of departures in 2020, Blake Cassels & Graydon remains firmly on the radar as a potent IP player in which total trust can be placed by companies looking to procure, enforce and monetise their assets. It has been locking down patent protection for Brookhaven Science Associates; Mirametrix, a developer of consumer electronics integrated with attention sensing technology; and global building materials company James Hardie. The heart and soul of the litigation practice are Melanie Baird and Andrew Skodyn. Dynamic lawyer Baird has made her mark tackling disputes relating to emerging technologies and has notched up several firsts, including presiding as counsel on Canada’s first biosimilar patent case. A tenacious advocate, Skodyn has a cracking pharmaceutical practice and commands the attention of the courtroom. The pair make a great team, having spent most of their careers working together, and have been busy representing Genentech, Biogen, F Hoffman-La Roche and Hoffman-La Roche Limited in an infringement and validity action concerning an innovative biologic treatment. Other highlights include acting for Facebook and Instagram. New recruit Christopher Hunter has settled into his role perfectly as captain of the commercial IP group. The mechanical engineer views intangible assets through a commercial lens and has been advising GlaxoSmithKline in connection with its collaboration with Medicago to develop, evaluate and manufacture an adjuvanted covid-19 vaccine candidate. Lululemon is another key client: Hunter shrewdly advised it on its acquisition of Mirror, a home fitness start-up.

Get unlimited access to all IAM content